Reference
Lee M, et al. Subcutaneous tocilizumab treatment in refractory adult onset still's disease. International Journal of Rheumatic Diseases 26 (Suppl. 1): 131, Jan 2023. Available from: URL: http://doi.org/10.1111/1756-185X.14505 [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab/disease-modifying-antirheumatics/etanercept. Reactions Weekly 1945, 22 (2023). https://doi.org/10.1007/s40278-023-34103-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-34103-z